Contact this trialFirst, we need to learn more about you.
Chemotherapy
CPX-351 + Glasdegib for Acute Myeloid Leukemia
Recruiting3 awardsPhase 2
Los Angeles, California
This trial is testing a combination of two drugs, CPX-351 and Glasdegib, in patients with a specific type of leukemia that is hard to treat. CPX-351 kills cancer cells, and Glasdegib stops them from growing. The goal is to see if this combination is effective for these patients.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service